Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-10-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
关于公司及子公司对下属项目公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the provision of guarantees by the company and its subsidiaries to project companies. It details the guarantee amounts, parties involved, board and supervisory opinions, and compliance with regulatory requirements. The content focuses on a specific corporate action related to financing guarantees rather than financial results, management changes, or legal proceedings. It is not a full financial report, earnings release, or management discussion. The document is a formal disclosure of a corporate guarantee arrangement, which fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company and its subsidiaries.
2024-10-27 Chinese
关于2024年前三季度计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provisions for the first three quarters of 2024. It details the amounts of impairment provisions made, the accounting policies and methods used, and the impact on the company's profit. The document is relatively short (2771 characters) and focuses on a specific accounting adjustment rather than presenting a full financial report. It does not contain comprehensive financial statements or a full quarterly report but rather a specific update on impairment provisions. This type of announcement is typical of a Regulatory Filing (RNS) as it provides regulatory disclosure about accounting estimates and provisions without being a full interim or annual report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-10-27 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "华蓝集团股份公司2024 年第三季度报告" which translates to "Hualan Group Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on shareholders and stock changes. The report covers the third quarter of 2024, indicating it is a quarterly financial report. It explicitly states it is unaudited and includes comprehensive financial metrics and analysis for the quarter. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data. The document is over 13,000 characters, so it is not a mere announcement or publication notice. Therefore, the correct classification is IR with high confidence. 9M 2024
2024-10-27 Chinese
第四届监事会第二十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 21st meeting of the 4th Supervisory Board of Huazhou Group. It includes details about the meeting's legality, attendance, and voting results on specific agenda items, such as the approval of the company's 2024 Q3 report and guarantees provided by subsidiaries. The document references the 2024 Q3 report but does not contain the report itself; instead, it directs readers to the full report published elsewhere. The document is short (952 characters) and serves as a meeting resolution announcement rather than a full financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-10-27 Chinese
第四届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the 20th meeting of the 4th Supervisory Board of Hualan Group Co., Ltd. It details the meeting date, attendance, agenda, and voting results regarding the use of idle raised funds for cash management. The document is short (801 characters) and serves as a meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed analysis, nor is it a regulatory certification or a report publication notice. The content fits best under a regulatory announcement category related to corporate governance and supervisory board decisions. Given the options, it does not fit AGM Information, Annual Report, Audit Report, or Management Reports. It is not a call transcript or capital update. It is a formal announcement of a board/supervisory meeting resolution, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-11 Chinese
太平洋证券股份有限公司关于华蓝集团股份公司使用部分闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from the sponsor (Pacific Securities Co., Ltd.) regarding the use of part of the idle raised funds by Hualan Group Co., Ltd. for cash management. It includes specifics about the fundraising, usage of funds, investment purposes, risk control measures, and approvals by the board and supervisory committee. The document references regulatory compliance and internal approvals but does not contain full financial statements or comprehensive financial performance data. It is a formal verification and opinion report related to the use of raised funds, not a full annual or interim report, earnings release, or audit report. The document length is 3575 characters, which is relatively short but contains substantive content beyond a mere announcement. It fits best as an Audit Report / Information (AR) because it is a standalone verification and opinion on the use of funds, including compliance and risk assessment, issued by the sponsor and auditor, rather than a full annual report or other category. H1 2024
2024-10-11 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.